Approaches of the Innate Immune System to Ameliorate Adaptive Immunotherapy for B-Cell Non-Hodgkin Lymphoma in Their Microenvironment

SIMPLE SUMMARY: The innate immune checkpoint blockade anti-CD47 antibodies combined with the anti-CD20 antibody rituximab can invigorate macrophage phagocytosis. Generally applied as vaccine adjuvants, TLR9 agonist CpG-oligodeoxynucleotides (CpG-ODNs) stimulate antigen presenting cells (APCs) and pl...

Descripción completa

Detalles Bibliográficos
Autor principal: Watanabe, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750340/
https://www.ncbi.nlm.nih.gov/pubmed/35008305
http://dx.doi.org/10.3390/cancers14010141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750340/
https://www.ncbi.nlm.nih.gov/pubmed/35008305
http://dx.doi.org/10.3390/cancers14010141

Ejemplares similares